Chemokine CCR3 antagonists

Bibliography

• BOUSQUETJ, CHANEZ P, LACOSTE JY et al: Eosinophilic inflammation in asthma. N. Engl.' Med. (1990) 323:1033–1039.
   PubMedGoogle Scholar
• TEIXEIRA MM, WILLIAMS TJ, HELLEWEL PG: Mechanisms and pharmacological manipulation of eosinophil accumulation in viva Trends. Pharmacol. Sri. (1995) 16:418–423.
   Google Scholar
• DESREUMAUX P, CAPRON M: Eosinophils in allergic reactions. Curt: Opin. Immunol. (1996) 8:790–795.
   PubMedGoogle Scholar
• ROTHENBERG ME: Eosinophilia. N Engl. I Med. (1998) 338:1592–1600.
   PubMed Web of Science ®Google Scholar
• GRIFFITHS-JOHNSON DA, COLLINS PD, ROSSI A et al.: The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem. Biophys. Res. Commun. (1993) 197:1167–1172.
   PubMed Web of Science ®Google Scholar
• JOSE PJ, GRIFFITHS-JOHNSON DA,COLLINS PD et al.: Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea-pig model of allergic airways inflammation. I Exp. Med. (1994) 179:881–887.
   Google Scholar
• GARCIA-ZEPEDA EA, ROTHENBERG ME, OWNBEY RT, CELESTIN J, LEDER P, LUSTER AD: Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat. Med. (1996) 2:449–456.
   PubMed Web of Science ®Google Scholar
• DAUGHERTY BL, SICILIANO SJ, DEMARTINO JA et al.: Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J. Exp. Med. (1996) 83:2349–2354.
   Google Scholar
• PONATH PD, QIN S, POST TW et al: Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. I. Exp. Med. (1996) 83:2437–2448.
   Google Scholar
• HEATH H, QIN S, RAO P et al.: Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. Clin. Invest. (1997) 99:178–184.
   Google Scholar
• UGUCCIONI M, MACKAY CR., OCHENSBERGER B et al: High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. I Clin. Invest. (1997) 100:1137–1143.
   Google Scholar
• SALLUSTO F, MACKAY CR, LANZAVECCHIA A: Selective expression of the eotaxin receptor CCR3 by human T-helper 2 cells. Science. (1997) 277:2005–2007.
   PubMed Web of Science ®Google Scholar
• OCHI H, HIRANI WM, YUAN Q et al.:T-helper cell Type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro.' Exp. Med. (1990) 190:267–280.
   Google Scholar
• SATO K, KAWASAKI H, NAGAYAMA H et al.: CC chemokine receptors, CCR-1 and CCR-3, are potentially involved in antigen-presenting cell function of human peripheral blood monocyte-derived dendritic cells. Blood (1999) 93:34–42.
   PubMedGoogle Scholar
• MATTOLI S, STACEY MA, SUN G et al: Eotaxin expression and eosinophilic inflammation in asthma. Biochem. Biophys. Res. Commun. (1997) 236:229–301.
   Google Scholar
• YING S, ROBINSO, DS, MENG Q et al.: Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant colocalization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur. Immunol. (1997) 27:3507–3516.
   Google Scholar
• LAMKHIOUED B, RENZI PM, ABI-YOUNES S et al: Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. I Immunol. (1997) 159:4593–4601.
   PubMed Web of Science ®Google Scholar
• TAHA RA, MINSHALL EM, MIOTTO D et al.: Eotaxin and monocyte chemotactic protein-4 mRNA expression in small airways of asthmatic and non-asthmatic individuals. I Allergy Clin. Immunol. (1999) 103:476–483.
   PubMed Web of Science ®Google Scholar
• GONZALO JA, LLOYD CM, KREMER Let al.: Eosinophil recruitment to the lung in a murine model of allergic inflammation: the role of T cells, chemokine, and adhesion receptors. Clin. Invest. (1996) 98:2332–2345.
   Google Scholar
• ROTHENBERG ME, MACLEAN JA, PEARLMAN E et al.: Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. I Exp. Med. (1997) 185:785–790.
   PubMed Web of Science ®Google Scholar
• MA W, BRYCE PJ, HUMBLES AA et al.:CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation.," Clin. Invest. (2002) 109:621–628.
   Google Scholar
• HUMBLES AA, LU B, FRIEND DS et al.: The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc. Nati Acad. Sci. USA (2002) 99:1479–1484.
   PubMed Web of Science ®Google Scholar
• NAYA A, SAEKI T: J-113863, chemokine CCR1 receptor antagonist. Drugs Fut. (2001) 26:121–127.
   Google Scholar
• NAYA A, SAGARA Y, OHVVAKI K et al.: Design, synthesis, and discovery of a novel CCR1 antagonist. I Med. Chem. (2001) 44:1429–1435.
   PubMed Web of Science ®Google Scholar
• DORN CP, FIMKE PE, OATES Bet al.:Antagonists of the human CCR5 receptor as anti-HIV-1. Part 1: discovery and initial structure-activity relationships for 1-amino-2-pheny1-4-(piperidine-1-yl)butanes. Bioorg. Med. Chem. Lett. (2001) 11:259–264.
   Google Scholar
• FIMKE PE, MEURER LC, OATES B et al.: Antagonists of the human CCR5 receptor as anti-HIV-1. Part 2: structure-activity relationships for substituted 2-aryl-1- [N-(methyl)-N-(phenylsulfonyl) aminol- 4 - (piperidine-1-yl)butanes. Bioorg. Med. Chem. Lett. (2001) 11:265–270.
   Google Scholar
• CASCIERI MA, SPRINGER MS: The chemokine/chemokine receptor family: potencial progress for therapeutic intervention. Curt: Opin. Chem. Biol. (2000) 4:420–427.
   PubMed Web of Science ®Google Scholar
• MASTROLORENZO A, SCOZZAFAVA A, SUPURAN CT: Small molecule antagonists of chemokine receptors as emerging anti-HIV agents. Expert Opin. The]: Patents (2001) 11:1245–1252.
   Web of Science ®Google Scholar
• WHITE JR, LEE JM, DEDE K et al: Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration. I Biol. Chem. (2000) 275(47):36626–36631.
   Web of Science ®Google Scholar
• DHANAK D, CHRISTMANN LT, DARCY MG et al: Discovery of potent and selective phenylalanine derived CCR3 receptor antagonist. Part 1. Bioorg Med. Chem. Lett. (2001) 11(11):1441–1444.
   Google Scholar
• DHANAK D, CHRISTMANN LT, DARCY MG et al: Discovery of potent and selective phenylalnine derived CCR3 receptor antagonist. Part 2. Bioorg. Med. Chem. Lett. (2001) 11 (11):1445–1450.
   Google Scholar
• BRYAN SA, JOSE PJ, TOPPING JR et al.: Responses of leukocytes to chemokines in whole blood and their antagonism by novel CC-chemokine receptor 3 antagonists. Am. I Respir. Grit. Care Med. (2002) 165:1602–1609.
   PubMed Web of Science ®Google Scholar
• NAYA A, KOBAYASHI K, ISHIKAWA M et al: Discovery of a novel CCR3 selective antagonist. Bioorg. Med. Chem. Lett. (2001) 11(9):1219–1223.
   PubMed Web of Science ®Google Scholar
• SAEKI T, OHWAKI K, NAYA A et al:Identification of a potent and nonpeptidyl CCR3 antagonist. Biochem. Biophys. Res. Commun. (2001) 281:779–782.
   PubMedGoogle Scholar
• NAYA A, KOBAYASHI K, ISHIKAWA M et al: Structure-activity relationships of 2-(benzothiazolyl-thio)acetamide class of CCR3 selective antagonist. Chem. Pharm. Bull. (2003) 51(6):697–701.
   PubMed Web of Science ®Google Scholar
• WACKER DA, SANTELLA JB III, GARDNER DS et al.: CCR3 antagonists: a potential new therapy for the treatment of asthma. Discovery and structure-activity relationships. Bioorg. Med. Chem. Lett. (2002) 12(13):1785–1789.
   PubMed Web of Science ®Google Scholar
• DE LUCCA GV, KIM UT, JOHNSON C et al: Discovery and structure-activity relationship of N-(ureidoalkyl)-benzyl-piperidines as potent small molecule CC chemokine receptor 3 (CCR3) antagonists.' Med. Chem. (2002) 45:3794–3804.
   Google Scholar
• ONUFFER JJ, HORUCK R. Chemokines, chemokine receptors and small molecule antagonists: recent developments. Trends PharmacoL ScL (2002) 23:459–467.
   PubMed Web of Science ®Google Scholar